Atlas Trials

The AP-GELP Study: A Clinical Trial on the Effects of Apremilast in Female Genital Erosive Lichen Planus

Clinical trial NCT03656666 · UNKNOWN

Trial details

NCT number
NCT03656666
Sponsor
Oslo University Hospital
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Lichen Planus of VulvaFemale Genital Disease
Start date
2019-09-24
Primary completion
2022-11-30
Enrollment
42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.